Bolette Hartmann

Publikation

Publikationer pr. år 1994 2014 2015 2016 2017 2018 2019 2020

• 155 Tidsskriftartikel
• 6 Konferenceabstrakt i tidsskrift
• 3 Konferenceartikel
• 2 Letter
• 4 Mere
  • 1 Bidrag til bog/antologi
  • 1 Konferenceabstrakt i proceedings
  • 1 Review
  • 1 Patent

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2015

  Pancreatic polypeptide responses to isoglycemic oral and intravenous glucose in humans with and without intact vagal innervation

  Veedfald, S., Plamboeck, A., Hartmann, B., Svendsen, L. B., Vilsbøll, T., Knop, F. K. & Holst, J. J., 14 aug. 2015, I: Peptides. 71, s. 229-31 3 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Pancreatic Polypeptide 100%
  • Glucose 45%
  • Dipeptidyl Peptidase 4 23%
  • Enteral 22%
  • Glucose Tolerance Test 17%
  10 Citationer (Scopus)

• Postprandial incretin and islet hormone responses and dipeptidyl-peptidase 4 enzymatic activity in patients with maturity onset diabetes of the young

  Østoft, S. H., Bagger, J. I., Hansen, T., Hartmann, B., Pedersen, O., Holst, J. J., Knop, F. K. & Vilsbøll, T., 1 aug. 2015, I: European Journal of Endocrinology. 173, 2, s. 205-215 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Mason-Type Diabetes 100%
  • Maturity-Onset Diabetes of the Young, Type 3 88%
  • Dipeptidyl Peptidase 4 88%
  • Incretins 85%
  • Maturity-Onset Diabetes of the Young, Type 2 78%
  9 Citationer (Scopus)

• Stability of glucagon-like peptide-1 and glucagon in human plasma

  Albrechtsen, N. J. W., Bak, M. J., Hartmann, B., Christensen, L. W., Kuhre, R. E., Deacon, C. & Holst, J. J., 16 jan. 2015, I: Endocrine Connections. 4, 1, s. 50-57 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Glucagon 88%
  • Ice 51%
  • Dipeptidyl-Peptidase IV Inhibitors 42%
  • Freezing 21%

• The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.

  Mandøe, M. J., Hansen, K. B., Hartmann, B., Rehfeld, J. F., Holst, J. J. & Hansen, H. S., 1 sep. 2015, I: The American Journal of Clinical Nutrition. 102, 3, s. 548-555 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Monoglycerides 100%
  • Olive Oil 80%
  • Dietary Fats 77%
  • Glucagon-Like Peptide 1 75%
  • Daucus carota 59%
  30 Citationer (Scopus)

• The anorexic hormone Peptide YY_3-36 is rapidly metabolized to inactive Peptide YY_3-34 in vivo.

  Toräng, S., Veedfald, S., Rosenkilde, M. M., Hartmann, B. & Holst, J. J., 20 jul. 2015, I: Physiological Reports. 3, 7, s. 1-8 8 s., e12455.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • peptide YY (3-36) 100%
  • Peptide YY 81%
  • Hormones 40%
  • Peptides 36%
  • Swine 36%
  15 Citationer (Scopus)

• The glucagon-like peptide 2 receptor is expressed in enteric neurons and not in the epithelium of the intestine

  Pedersen, J., B. Pedersen, N., Brix, S. W., Grunddal, K. V., Rosenkilde, M. M., Hartmann, B., Ørskov, C., S. Poulsen, S. & Holst, J. J., maj 2015, I: Peptides. 67, s. 20-28 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Glucagon-Like Peptide-2 Receptor 90%
  • Enteric Coating 67%
  • Intestines 44%
  • Epithelium 37%
  25 Citationer (Scopus)

• The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1

  Plamboeck, A., Veedfald, S., Deacon, C. F., Hartmann, B., Vilsbøll, T., Knop, F. K. & Holst, J. J., 3 sep. 2015, I: American Journal of Physiology: Regulatory, Integrative and Comparative Physiology. 309, 5, s. R544-51 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Atropine 86%
  • Cholinergic Agents 79%
  • Glucagon 20%
  • Glucose 12%
  17 Citationer (Scopus)

• Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes

  Christensen, M., Sparre-Ulrich, A. H., Hartmann, B., Grevstad, U., Rosenkilde, M. M., Holst, J. J., Vilsbøll, T. & Knop, F. K., 1 nov. 2015, I: International journal of obesity (2005). 39, 11, s. 1651-1654 4 s.

  Publikation: Bidrag til tidsskrift › Letter › peer review

  • Liraglutide 100%
  • Cerebrospinal Fluid 61%
  • Type 2 Diabetes Mellitus 53%
  • Weight Loss 21%
  • Body Weight 6%
  28 Citationer (Scopus)
• 2014

  Effects of chronic glucagon-like peptide-2 therapy during weaning in neonatal pigs

  Sigalet, D. L., de Heuvel, E., Wallace, L., Bulloch, E., Turner, J., Wales, P. W., Nation, P., Wizzard, P. R., Hartmann, B., Assad, M. & Holst, J. J., 10 jan. 2014, I: Regulatory Peptides. 188, s. 70-80 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Weaning 53%
  • Swine 39%
  • Small Intestine 15%
  • Animals 13%
  30 Citationer (Scopus)

• Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans

  Kuhre, R. E., Gribble, F. M., Hartmann, B., Reimann, F., Windeløv, J. A., Rehfeld, J. F. & Holst, J. J., 1 apr. 2014, I: American Journal of Physiology: Gastrointestinal and Liver Physiology. 306, 7, s. G622-30 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Fructose 97%
  • Peptides 54%
  • Glucose 53%
  • peptide YY (3-36) 18%
  65 Citationer (Scopus)

• GLP-1 Amidation Efficiency Along the Length of the Intestine in Mice, Rats and Pigs and in GLP-1 Secreting Cell Lines

  Kuhre, R. E., Albrechtsen, N. J. W., Windeløv, J. A., Svendsen, B., Hartmann, B. & Holst, J. J., maj 2014, I: Peptides. 55, s. 52-57 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Intestines 77%
  • Swine 67%
  • Length 50%
  • Cell Line 50%
  35 Citationer (Scopus)

• Glucagon-like peptide 2 treatment may improve intestinal adaptation during weaning

  Thymann, T., Le Huërou-Luron, I., Petersen, Y. M., Hedemann, M. S., Elinf, J., Jensen, B. B., Holst, J. J., Hartmann, B. & Sangild, P. T., maj 2014, I: Journal of Animal Science. 92, 5, s. 2070-2079 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • glucagon-like peptide 2 100%
  • Glucagon-Like Peptide 2 93%
  • Weaning 63%
  • weaning 51%
  • diarrhea 32%
  21 Citationer (Scopus)

• Glucose-dependent insulinotropic polypeptide inhibits bone resorption in humans

  Nissen, A., Christensen, M., Knop, F. K., Vilsbøll, T., Holst, J. J. & Hartmann, B., 1 nov. 2014, I: The Journal of clinical endocrinology and metabolism. 99, 11, s. E2325-9 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Insulinotropic 100%
  • Bone Resorption 60%
  • Polypeptide 49%
  • Peptides 38%
  • Glucose 37%
  74 Citationer (Scopus)

• Glutamate prevents intestinal atrophy via luminal nutrient sensing in a mouse model of total parenteral nutrition

  Xiao, W., Feng, Y., Holst, J. J., Hartmann, B., Yang, H. & Teitelbaum, D. H., maj 2014, I: FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 28, 5, s. 2073-87 15 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Parenteral 100%
  • Total Parenteral Nutrition 92%
  • Nutrient 82%
  • Glutamic Acid 68%
  • Atrophy 67%
  30 Citationer (Scopus)

• Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?

  Albrechtsen, N. J. W., Hartmann, B., Veedfald, S., Windeløv, J. A., Plamboeck, A., Bojsen-Møller, K. N., Idorn, T., Feldt-Rasmussen, B., Knop, F. K., Vilsbøll, T., Madsbad, S., Deacon, C. F. & Holst, J. J., sep. 2014, I: Diabetologia. 57, 9, s. 1919-1926 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon 100%
  • Enzyme-Linked Immunosorbent Assay 67%
  • Glicentin 22%
  • Gastric Bypass 22%
  • Chronic Kidney Failure 16%
  110 Citationer (Scopus)

• No Effect of Aprotinin (Trasylol) on Degradation of Exogenous and Endogenous Glucagon in Human, Mouse and Rat Plasma

  Bak, M. J., Albrechtsen, N. J. W., Hartmann, B., Pedersen, J., Christensen, M., Vilsboll, T., Knop, F. K., Deacon, C. F., Dragsted, L. O. & Holst, J. J., 2014, I: Journal of Endocrinology and Diabetes. 1, 1, s. 1-5 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• Provision of amniotic fluid during parenteral nutrition increases weight gain with limited effects on gut structure, function, immunity, and microbiology in newborn preterm pigs

  Østergaard, M. V., Shen, R. L., Støy, A. C. F., Skovgaard, K., Krych, Ł., Leth, S. S., Nielsen, D. S., Hartmann, B., Bering, S. B., Schmidt, M. & Sangild, P. T., maj 2014, I: Journal of Parenteral and Enteral Nutrition. 40, 4, s. 552-566 15 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Parenteral Nutrition 100%
  • Amniotic Fluid 95%
  • Microbiology 93%
  • Weight Gain 81%
  • Immunity 72%
  17 Citationer (Scopus)

• Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans

  Bak, M. J., Wewer Albrechtsen, N. J., Pedersen, J., Hartmann, B., Christensen, M., Vilsbøll, T., Knop, F. K., Deacon, C. F., Dragsted, L. O. & Holst, J. J., apr. 2014, I: European Journal of Endocrinology. 170, 4, s. 529-538 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Oxyntomodulin 100%
  • Glucagon 60%
  • Sensitivity and Specificity 43%
  • Glicentin 29%
  • Peptides 15%
  94 Citationer (Scopus)

• Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): Implications for GLP-1 measurements in clinical studies

  Bak, M. J., Albrechtsen, N. J. W., Pedersen, J., Knop, F. K., Vilsbøll Lauritsen, T., Jørgensen, N. B., Hartmann, B., Deacon, C. F., Dragsted, L. O. & Holst, J. J., 1 nov. 2014, I: Diabetes, Obesity and Metabolism. 16, 11, s. 1155-1164 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Sensitivity and Specificity 63%
  • Clinical Studies 59%
  • Protein Isoforms 21%
  • Buffers 18%
  56 Citationer (Scopus)

• Stimulation of intestinal growth and function with DPP-IV inhibition in a mouse short bowel syndrome model

  Sueyoshi, R., Ignatoski, K. M. W., Okawada, M., Hartmann, B., Holst, J. J. & Teitelbaum, D. H., 15 aug. 2014, I: American Journal of Physiology: Gastrointestinal and Liver Physiology. 307, 4, s. G410-19 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Short Bowel Syndrome 100%
  • Glucagon-Like Peptide 2 86%
  • Glucagon-Like Peptide-2 Receptor 67%
  • Epithelial Cells 39%
  • MK0626 39%
  16 Citationer (Scopus)

• The incretin effect does not differ in trained and untrained, young, healthy men

  Lund, M. T., Dalby, S., Hartmann, B., Helge, J. W., Holst, J. J. & Dela, F., mar. 2014, I: Acta Physiologica. 210, 3, s. 565-72 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Incretins 100%
  • Glucose 48%
  • Insulin 28%
  • Glucagon-Like Peptide 1 27%
  • Insulin Secretion 23%
  9 Citationer (Scopus)
• 2013

  Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study

  Madsen, K. B., Askov-Hansen, C., Naimi, R. M., Brandt, C. F., Hartmann, B., Holst, J. J., Mortensen, P. B. & Jeppesen, P. B., 10 jun. 2013, I: Regulatory Peptides. 184, 10, s. 30-9 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Glucagon-Like Peptide 1 78%
  • Short Bowel Syndrome 67%
  • Intestinal Absorption 56%
  • Placebos 34%
  50 Citationer (Scopus)

• A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients

  Naimi, R. M., Madsen, K. B., Askov-Hansen, C., Brandt, C. F., Hartmann, B., Holst, J. J., Mortensen, P. B. & Jeppesen, P. B., 10 jun. 2013, I: Regulatory Peptides. 184, 10, s. 47-53 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Short Bowel Syndrome 67%
  • Meals 44%
  • Peptide 28%
  • Injections 28%
  6 Citationer (Scopus)

• A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients

  Sigalet, D. L., Kravarusic, D., Butzner, D., Hartmann, B., Holst, J. J. & Meddings, J., okt. 2013, I: Canadian Journal of Gastroenterology. 27, 10, s. 587-92 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Crohn Disease 60%
  • Pediatrics 40%
  • Ileal Diseases 19%
  • Permeability 16%
  9 Citationer (Scopus)

• Characterization of oral and intravenous glucose handling in truncally vagotomised subjects with pyloroplasty

  Plamboeck, A., Veedfald, S., Deacon, C., Hartmann, B., Wettergren, A., Svendsen, L. B., Meisner, S., Hovendal, C., Knop, F. K., Vilsbøll, T. & Holst, J. J., aug. 2013, I: European Journal of Endocrinology. 169, s. 187-201 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucose 100%
  • Glucagon-Like Peptide 1 82%
  • Glucose Tolerance Test 71%
  • Glucagon 55%
  • Incretins 45%
  42 Citationer (Scopus)

• Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure

  Askov-Hansen, C., Jeppesen, P. B., Lund, P., Hartmann, B., Holst, J. J. & Henriksen, D. B., 10 feb. 2013, I: Regulatory Peptides. 181, s. 4-8 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Sitagliptin 80%
  • Sitagliptin Phosphate 52%
  • Subcutaneous Injections 51%
  • Bone Resorption 50%
  16 Citationer (Scopus)

• Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis

  Kissow, H., Hartmann, B., Holst, J. J. & Poulsen, S. S., dec. 2013, I: Gut.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Mucositis 100%
  • Glucagon-Like Peptide 1 97%
  • Glucagon-Like Peptide 2 78%
  • Drug Therapy 48%
  • exendin (9-39) 41%
  32 Citationer (Scopus)

• Glucagon-like peptide-2 induces rapid digestive adaptation following intestinal resection in preterm neonates

  Vegge, A., Thymann, T., Lund, P., Stoll, B., Bering, S. B., Hartmann, B., Jelsing, J., Qvist, N., Burrin, D. G., Jeppesen, P. B., Holst, J. J. & Sangild, P. T., 8 maj 2013, I: American Journal of Physiology: Gastrointestinal and Liver Physiology. 305, 4, s. G277-G285 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Short Bowel Syndrome 53%
  • Newborn Infant 48%
  • Swine 37%
  • Jejunostomy 21%
  37 Citationer (Scopus)

• Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin

  Holst, J. J., Deacon, C. F., Hartmann, B. & Pedersen, J., 2013, Handbook of Biologically Active Peptides . Kastin, AJ. (red.). 2 udg. Elsevier, s. 1241-1250 10 s.

  Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Undervisning

• Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass

  Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., Jacobsen, S. H., Clausen, T. R., Worm, D., Hartmann, B., Rehfeld, J. F., Damgaard, M., Madsen, J. L., Madsbad, S., Holst, J. J. & Hansen, D. L., nov. 2013, I: International Journal of Obesity. 37, s. 1452-1459 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Gastric Bypass 100%
  • Energy Metabolism 78%
  • Glucagon-Like Peptide 1 76%
  • Weight Loss 71%
  • Hormones 61%
  149 Citationer (Scopus)

• Meal induced gut hormone secretion is altered in aerobically trained compared to sedentary young healthy males

  Lund, M. T., Taudorf, L., Hartmann, B., Helge, J. W., Holst, J. J. & Dela, F., 1 nov. 2013, I: European Journal of Applied Physiology. 113, 11, s. 2737-47 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • meals 100%
  • Meals 84%
  • Hormones 66%
  • Incretins 61%
  • Glucagon-Like Peptide 1 55%
  8 Citationer (Scopus)

  3525 Downloads (Pure)

• The Effect of Exogenous GLP-1 on Food Intake is Lost in Male Truncally Vagotomized Subjects with Pyloroplasty

  Plamboeck, A., Veedfald, S., Deacon, C. F., Hartmann, B., Wettergren, A., Svendsen, L. B., Meisner, S., Hovendahl, C., Vilsboll, T., Knop, F. K. & Holst, J. J., 16 jun. 2013, I: American Journal of Physiology: Gastrointestinal and Liver Physiology. 304, s. G1117-G1127 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Eating 64%
  • Meals 22%
  • Gastric Emptying 19%
  • Glucagon 17%
  94 Citationer (Scopus)
• 2012

  Continuous parenteral and enteral nutrition induces metabolic dysfunction in neonatal pigs

  Stoll, B., Puiman, P. J., Cui, L., Chang, X., Benight, N. M., Bauchart-Thevret, C., Hartmann, B., Holst, J. J. & Burrin, D. G., sep. 2012, I: Journal of Parenteral and Enteral Nutrition. 36, 5, s. 538-50 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Parenteral Nutrition 100%
  • Enteral Nutrition 94%
  • Swine 69%
  • Formulated Food 55%
  • Small Intestine 44%
  33 Citationer (Scopus)

• Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine

  Kissow, H., Viby, N-E., Hartmann, B., Holst, J. J., Timm, M., Thim, L. & Poulsen, S. S., jul. 2012, I: Cancer Chemotherapy and Pharmacology. Supplement. 70, 1, s. 39-48 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Mucositis 76%
  • Small Intestine 57%
  • Drug Therapy 37%
  • Intestines 31%
  27 Citationer (Scopus)

• Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice

  Kissow, H., Hartmann, B., Holst, J. J., Viby, N-E., Hansen, L. S., Rosenkilde, M. M., Hare, K. J. & Poulsen, S. S., 10 nov. 2012, I: Regulatory Peptides. 179, 1-3, s. 91-100 10 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Liraglutide 100%
  • Glucagon-Like Peptide 2 84%
  • Glucagon-Like Peptide 1 82%
  • Dipeptidyl Peptidase 4 69%
  • Glucagon-Like Peptide-1 Receptor 67%
  59 Citationer (Scopus)

• Intestinal adaptation is stimulated by partial enteral nutrition supplemented with the prebiotic short-chain fructooligosaccharide in a neonatal intestinal failure piglet model

  Barnes, J. L., Hartmann, B., Holst, J. J. & Tappenden, K. A., sep. 2012, I: Journal of Parenteral and Enteral Nutrition. 36, 5, s. 524-37 14 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • fructooligosaccharide 100%
  • Prebiotics 78%
  • Enteral Nutrition 65%
  • Lactobacillus rhamnosus 43%
  • Synbiotics 34%
  31 Citationer (Scopus)

• Randomised controlled trial of colostrum to improve intestinal function in patients with short bowel syndrome

  Lund, P., Sangild, P. T., Aunsholt, L., Hartmann, B., Holst, J. J., Mortensen, J., Mortensen, P. B. & Jeppesen, P. B., sep. 2012, I: European Journal of Clinical Nutrition. 66, 9, s. 1059-1065 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Short Bowel Syndrome 100%
  • Colostrum 99%
  • Randomized Controlled Trials 49%
  • Nutrients 31%
  • Water-Electrolyte Balance 29%
  17 Citationer (Scopus)
• 2011

  Glucagon-like peptide 2 (Glp-2) stimulates intestinal function during weaning

  Thymann, T., Huërou-Luron, I. L., Petersen, Y. M., Hedemann, M. S., Elnif, J., Jensen, B. B., Hartmann, B., Holst, J. J. & Sangild, P. T., 2011, 44th annual meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, 2011: programme and abstract booklet. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), s. 202 1 s.

  Publikation: Bidrag til bog/antologi/rapport › Konferenceabstrakt i proceedings › Forskning

• Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1

  Torekov, S. S., Ma, L., Grarup, N., Hartmann, B., Hainerová, I. A., Kielgast, U., Kissow, H., Rosenkilde, M., Lebl, J., Witte, D. R., Jørgensen, T., Sandbaek, A., Lauritzen, T., Madsen, O. D., Wang, J., Linneberg, A., Madsbad, S., Holst, J. J., Hansen, T., Pedersen, O., & 1 flereGIANT Consortium, nov. 2011, I: Diabetologia. 54, 11, s. 2820-31 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 1 100%
  • Glucagon 88%
  • Fasting 68%
  • Alleles 62%
  • Insulin 58%
  13 Citationer (Scopus)

• Reduction of parathyoid hormone levels

  Hartmann, B. & B. Henriksen, D., 1 apr. 2011, Patentnr. US2010/0081,622, 28 sep. 2009

  Publikation: Patent

  • Plasma Level 100%
  • Hormone 80%
  • Pharmaceutical 58%
  • Reduction 36%

• The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

  Bremholm, L., Hornum, M., Andersen, U. B., Hartmann, B., Holst, J. J. & Jeppesen, P. B., 7 jun. 2011, I: Regulatory Peptides. 168, 1-3, s. 32-8 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Jejunostomy 67%
  • Short Bowel Syndrome 22%
  • Flow 15%
  • Superior Mesenteric Artery 14%
  62 Citationer (Scopus)
• 2010

  The intestinotrophic peptide, GLP-2, counteracts the gastrointestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, erlotinib, and cisplatin

  Rasmussen, A. R., Viby, N-E., Hare, K. J., Hartmann, B., Thim, L., Holst, J. J. & Poulsen, S. S., 1 okt. 2010, I: Digestive Diseases and Sciences. 55, 10, s. 2785-96 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • mouse EGFR protein 100%
  • Glucagon-Like Peptide 2 89%
  • Erlotinib Hydrochloride 71%
  • Cisplatin 50%
  • Atrophy 49%
  18 Citationer (Scopus)
• 2009

  Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD

  Henriksen, D. B., Alexandersen, P., Hartmann, B., Adrian, C. L., Byrjalsen, I., Bone, H. G., Holst, J. J. & Christiansen, C., 2009, I: Bone. 45, 5, s. 833-42 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Hip 52%
  • Placebos 43%
  • Osteogenesis 22%
  • Injections 14%
  124 Citationer (Scopus)

• Long-term exendin-4 treatment delays natural deterioration of glycaemic control in diabetic Goto-Kakizaki rats

  Simonsen, L., Pilgaard, S., Orskov, C., Hartmann, B., Holst, J. J. & Deacon, C. F., 2009, I: Diabetes, Obesity and Metabolism. 11, 9, s. 884-90 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Exenatide 100%
  • Time-to-Treatment 81%
  • Animals 31%
  • Hemoglobins 16%
  • Glucagon-Like Peptide-1 Receptor 13%
  6 Citationer (Scopus)
• 2008

  Effects of treatment with glucagon-like peptide-2 on bone resorption in colectomized patients with distal ileostomy or jejunostomy and short-bowel syndrome

  Gottschalck, I. B., Jeppesen, P. B., Hartmann, B., Holst, J. J. & Henriksen, D. B., 2008, I: Scandinavian Journal of Gastroenterology. 43, 11, s. 1304-10 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Jejunostomy 86%
  • Short Bowel Syndrome 86%
  • Ileostomy 79%
  • Bone Resorption 64%
  31 Citationer (Scopus)

• Functional ontogeny of the proglucagon-derived peptide axis in the premature human neonate

  Amin, H., Holst, J. J., Hartmann, B., Wallace, L., Wright, J. & Sigalet, D. L., jan. 2008, I: Pediatrics. 121, 1, s. e180-6

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Proglucagon 100%
  • Glucagon-Like Peptide 2 99%
  • Glucagon-Like Peptide 1 64%
  • Newborn Infant 48%
  • Peptides 40%
  32 Citationer (Scopus)
• 2007

  Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate

  Holst, J. J., Hartmann, B., Gottschalck, I. B., Jeppesen, P. B., Miholic, J. & Henriksen, D. B., jul. 2007, I: Scandinavian Journal of Gastroenterology. 42, 7, s. 814-20 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Short Bowel Syndrome 86%
  • Bone Resorption 64%
  • Gastrectomy 28%
  • Meals 24%
  32 Citationer (Scopus)

• Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women

  Henriksen, D. B., Alexandersen, P., Hartmann, B., Adrian, C. L., Byrjalsen, I., Bone, H. G., Holst, J. J. & Christiansen, C., mar. 2007, I: Bone. 40, 3, s. 723-9 7 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Bone Resorption 64%
  • Osteogenesis 55%
  • Collagen Type I 27%
  • Osteocalcin 19%
  98 Citationer (Scopus)

• Glucagon-like peptide-2 in umbilical cord blood from mature infants

  Bodé, S., Hartmann, B., Holst, J. J. & Greisen, G., 2007, I: Neonatology. 91, 1, s. 49-53 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Fetal Blood 62%
  • Cesarean Section 16%
  • Parturition 15%
  • Gestational Age 14%
  2 Citationer (Scopus)
• 2005

  Glucagon-like peptide-2 (GLP-2) response to enteral intake in children during anti-cancer treatment

  Andreassen, B. U., Paerregaard, A., Schmiegelow, K., Rechnitzer, C., Heilman, C., Hartmann, B., Holst, J. J. & Michaelsen, K. F., jan. 2005, I: Journal of Pediatric Gastroenterology and Nutrition. 40, 1, s. 48-53 6 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Glucagon-Like Peptide 2 100%
  • Small Intestine 57%
  • Energy Intake 36%
  • Child 27%
  • Enteroendocrine Cells 25%
  2 Citationer (Scopus)